Cancer patient survival in Estonia 1995-2009: Time trends and data quality

Cancer Epidemiology

Volumn 38, Issue 3, 2014, Pages 253-258

  Innos, K ^a   Baburin, A ^a   Aareleid, T ^a  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

Author keywords

Cancer registry; Data quality; Incidence; Mortality; Period analysis; Population based; Relative survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ANUS CANCER; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; DEATH CERTIFICATE; ESTONIA; ESTONIAN CANCER REGISTRY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; KIDNEY PELVIS CANCER; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SKIN CANCER; STOMACH CANCER; TRACHEA CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; INCIDENCE; METHODOLOGY; MORTALITY; NEOPLASMS; REGISTER; SURVIVAL; SURVIVAL RATE; TRENDS;

ESTONIA; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; REGISTRIES; RESEARCH DESIGN; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84900495135     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.03.008     Document Type: Article

References (44)

1. Sant M., Aareleid T., Berrino F., Bielska L.M., Carli P.M., Faivre J., et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 2003, 14(Suppl. 5):v61-v118.
2. Gondos A., Bray F., Hakulinen T., Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 2009, 20:564-573.
3. Aareleid T., Brenner H. Trends in cancer patient survival in Estonia before and after the transition from a Soviet republic to an open-market economy. Int J Cancer 2002, 102:45-50.
4. Aareleid T., Rahu M. Cancer survival in Estonia from 1978 to 1987. Cancer 1991, 68:2088-2092.
5. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J, editors. Survival of cancer patients in Europe: the EUROCARE Study. IARC Scientific Publications No. 132. Lyon: International Agency for Research on Cancer; 1995.
6. Sant M., Allemani C., Santaquilani M., Knijn A., Marchesi F., Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009, 45:931-991.
7. Rahu M., McKee M. Epidemiological research labelled as a violation of privacy: the case of Estonia. Int J Epidemiol 2008, 37:678-682.
8. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer Registration Principles and Methods. IARC Scientific Publication No. 95. Lyon: International Agency for Research on Cancer; 1991.
9. Capocaccia R., Gatta G., Roazzi P., Carrani E., Santaquilani M., De Angelis R., et al. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 2003, 14(Suppl. 5):v14-v27.
10. De Angelis R., De Angelis R., Sant M., Coleman M.P., Francisci S., Baili P., et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014, 15:23-34.
11. Rahu M. Estonia. Cancer incidence in five continents 1997, vol. VII:569-573. International Agency for Research on Cancer, Lyon.
12. Parkin D.M., Bray F. Evaluation of data quality in the cancer registry: principles and methods. Part II. Completeness. Eur J Cancer 2009, 45:756-764.
13. Bray F., Parkin D.M. Evaluation of data quality in the cancer registry: principles and methods. Part I. Comparability, validity and timeliness. Eur J Cancer 2009, 45:747-755.
14. Innos K., Rahu M., Rahu K. Feasibility of cohort studies in Estonia. Occup Environ Med 1999, 56:499-502.
15. Ederer F., Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note no. 10 1959, National Cancer Institute, Bethesda, MD, End Results Evaluation Section.
16. Brenner H., Gefeller O., Hakulinen T. Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004, 40:326-335.
17. Talbäck M., Dickman P.W. Predicting the survival of cancer patients recently diagnosed in Sweden and an evaluation of predictions published in 2004. Acta Oncol 2012, 51:17-27.
18. Brenner H., Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 2004, 40:2494-2501.
19. Corazziari I., Quinn M., Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004, 40:2307-2316.
20. Dickman PW, Coviello E, Hills M. Estimating and modelling relative survival. Available at: [accessed October 2013]. http://www.pauldickman.com/survival/strs.pdf.
21. Statistics Estonia Statistical Database. Available at: [accessed January 2014]. http://pub.stat.ee/px-web.2001/dialog/statfile1.asp.
22. Ades F., Senterre C., de Azambuja E., Sullivan R., Popescu R., Parent F., et al. Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states. Ann Oncol 2013, 24:2897-2902.
23. Giordano L., von Karsa L., Tomatis M., Majek O., de Wolf C., Lancucki L., et al. Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen 2012, 19(Suppl. 1):72-82.
24. Maver P.J., Seme K., Korać T., Dimitrov G., Döbrossy L., Engele L., et al. Cervical cancer screening practices in central and eastern Europe in 2012. Acta Dermatovenerol Alp Pannonica Adriat 2013, 22:7-19.
25. De Angelis R., Francisci S., Baili P., Marchesi F., Roazzi P., Belot A., et al. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. Eur J Cancer 2009, 45:909-930.
26. Brenner H., Hakulinen T. Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration. Br J Cancer 2005, 92:576-579.
27. Pollock A.M., Vickers N. Why are a quarter of all cancer deaths in south-east England registered by death certificate only? Factors related to death certificate only registrations in the Thames Cancer Registry between 1987 and 1989. Br J Cancer 1995, 71:637-641.
28. Robinson D., Sankila R., Hakulinen T., Møller H. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer 2007, 43:909-913.
29. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013, 49:1374-1403.
30. National Institute for Health Development. Health statistics and health research database. Available at: [accessed January 2014]. http://pxweb.tai.ee/esf/pxweb2008/dialog/statfile1.asp.
31. International Agency for Research on Cancer A review of human carcinogens: personal habits and indoor combustions. IARC Monographs on the evaluation of carcinogenic risks to humans 2012, vol. 100E. International Agency for Research on Cancer, Lyon.
32. Hakulinen T., Tryggvadóttir L., Gislum M., Storm H.H., Bray F., Klint A., et al. Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010, 49:561-577.
33. Birgisson H., Talbäck M., Gunnarsson U., Pahlman L., Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005, 31:845-853.
34. Glimelius B., Grönberg H., Jarhult J., Wallgren A., Cavallin-Stahl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003, 42:476-492.
35. Smedh K., Olsson L., Johansson H., Aberg C., Andersson M. Reduction of postoperative morbidity and mortality in patients with rectal cancer following the introduction of a colorectal unit. Br J Surg 2001, 88:273-277.
36. Innos K., Soplepmann J., Suuroja T., Melnik P., Aareleid T. Survival for colon and rectal cancer in Estonia: role of staging and treatment. Acta Oncol 2012, 51:521-527.
37. Gatta G., Zigon G., Aareleid T., Ardanaz E., Bielska-Lasota M., Galceran J., et al. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study. Acta Oncol 2010, 49:776-783.
38. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., Coebergh J.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990. Eur J Cancer 2008, 44:1345-1389.
39. Thjodleifsson B., Asbjornsdottir H., Sigurjonsdottir R.B., Gislason D., Olafsson I., Cook E., et al. Seroprevalence of Helicobacter pylori and cagA antibodies in Iceland, Estonia and Sweden. Scand J Infect Dis 2007, 39:683-689.
40. Oona M., Utt M., Nilsson I., Uibo O., Vorobjova T., Maaroos H.I. Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes. Helicobacter 2004, 9:233-241.
41. Baburin A., Aareleid T., Padrik P., Valvere V., Innos K. Time trends in population-based breast cancer survival in Estonia: analysis by age and stage. Acta Oncol 2014, 53:226-234.
42. Neppl-Huber C., Zappa M., Coebergh J.W., Rapiti E., Rachtan J., Holleczek B., et al. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol 2012, 23:1325-1334.
43. Engholm G., Hakulinen T., Gislum M., Tryggvadóttir L., Klint A., Bray F., et al. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010, 49:655-664.
44. Storm H.H., Klint A., Tryggvadóttir L., Gislum M., Engholm G., Bray F., et al. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010, 49:694-712.